Compare Cardinal Health Inc (CAH) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs MasterCard Inc — how do they compare? Cardinal Health Inc trades at $224.5 (market cap $53.89B), while MasterCard Inc trades at $535 (market cap $475.39B). The key difference: MasterCard Inc is far larger — about 8.8× Cardinal Health Inc's market cap, and Cardinal Health Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| CAH | MA | |
|---|---|---|
Market Cap | $53.89B | $475.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $239.71 | $598.96 |
52-Week Low | $146.04 | $471.55 |
Enterprise Value | $58.87B | $486.13B |
Dividend Yield | 0.89% | 0.65% |
Volume | — | 4,635,698 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Mastercard (MA) trades at $538.02, up 0.06% on the day, with a bullish technical outlook supported by moving averages and strong institutional buying. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding the $4.41 estimate. Revenue grew to $32.79B in 2025, while net income margin remains high at 45.88%. Analyst consensus is strongly bullish with a $634.27 price target, reflecting confidence in continued payment volume growth and digital expansion initiatives.
The stock offers upside potential from consistent execution and market share gains in digital payments, but faces risks from competitive disruption by stablecoins and regulatory scrutiny. Cash flow strength supports shareholder returns via dividends, with the next $0.87 payment scheduled for August 2026. Valuation multiples like P/E of 31.14 are elevated but justified by high profitability and growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
